EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY 4.0

Assessing actionability and incidental findings of germline variants in two precision oncology trials

Maria Baz Ibrahim, Yahia Adnani, Gérôme Jules Clément, Ludovic Lacroix, Yohann Loriot, Benjamin Besse, Christophe Massard, Etienne Rouleau

European Journal of Cancer · 2024

DOI: 10.1016/j.ejca.2024.114256 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift European Journal of Cancer, 2024. Verfasst von Maria Baz Ibrahim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of oncogenetics and biochemistry, Paul Brousse University Hospital (APHP), 12 Av. Paul Vaillant Couturier, 94800 Villejuif, France. Electr…. Hauptthemen laut MEDLINE: Germ-Line Mutation, Incidental Findings, Neoplasms, Precision Medicine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Germ-Line MutationIncidental FindingsNeoplasmsPrecision MedicineAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedBiomarkers, TumorGenetic Predisposition to DiseaseGenetic TestingHigh-Throughput Nucleotide Sequencing

Stichwörter der Autor:innen

Basket trialGermline DNA variantsIncidental variantsPrecision oncologyTargeted therapy

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of oncogenetics and biochemistry, Paul Brousse University Hospital (APHP), 12 Av. Paul Vaillant Couturier, 94800 Villejuif, France. Electronic address: maria.baz.baz@hotmail.com.
  • Bioinformatics Core Facility, Gustave Roussy Cancer Campus, Villejuif, France.
  • Molecular Biopathology, Medical Biology and Pathology Department, Gustave-Roussy Cancer Campus, Villejuif, France.
  • Department of Medical Oncology, Gustave Roussy, 94805 Villejuif, France.
  • Eugene Marquis Cancer Center, Rennes, France.
  • Cancer Genetics Laboratory, Medical Biology and Pathology Department, Gustave-Roussy Cancer Campus, Villejuif, France.

Zitieren

APA

Ibrahim, M. B., Adnani, Y., Clément, G. J., Lacroix, L., Loriot, Y., Besse, B., Massard, C., & Rouleau, E. (2024). Assessing actionability and incidental findings of germline variants in two precision oncology trials. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2024.114256

Vancouver

Ibrahim MB, Adnani Y, Clément GJ, Lacroix L, Loriot Y, Besse B, et al. Assessing actionability and incidental findings of germline variants in two precision oncology trials. European Journal of Cancer. 2024. doi:10.1016/j.ejca.2024.114256

BibTeX
@article{Ibrahim2024,
  author = {Ibrahim, Maria Baz and Adnani, Yahia and Clément, Gérôme Jules and Lacroix, Ludovic and Loriot, Yohann and Besse, Benjamin and Massard, Christophe and Rouleau, Etienne},
  title = {Assessing actionability and incidental findings of germline variants in two precision oncology trials},
  journal = {European Journal of Cancer},
  year = {2024},
  doi = {10.1016/j.ejca.2024.114256}
}
Kostenlos starten →